Literature DB >> 11427550

Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species.

E Mellado1, T M Diaz-Guerra, M Cuenca-Estrella, J L Rodriguez-Tudela.   

Abstract

Two cyp51-related genes (cyp51A and cyp51B) encoding 14-alpha sterol demethylase-like enzymes were identified in the opportunistic human pathogen Aspergillus fumigatus. PCR amplification using degenerate oligonucleotides based on conserved areas of cytochrome P450 demethylases of other filamentous fungi and yeasts allowed the cloning and sequencing of two different homologue genes in A. fumigatus. Southern analysis confirmed that both genes hybridized to distinct genomic loci and that both are represented as single copies in the genome. Comparison of the deduced Cyp51A and Cyp51B proteins with the CYP51 proteins from Penicillium italicum, Aspergillus nidulans, Erysiphe graminis, Uncinula necator, Botrytis cinerea, Ustilago maydis, Cryptococcus neoformans, Candida albicans, Saccharomyces cerevisiae, Candida tropicalis, and Candida glabrata showed that the percentages of identity of the amino acid sequences (range, 40 to 70%) were high enough to consider Cyp51A and Cyp51B to be members of the fungal CYP51 family. Fragments from both genes were also cloned from other Aspergillus spp. (A. flavus, A. nidulans, and A. terreus). Phylogenetic analysis showed that, at least in the most pathogenic species of Aspergillus, there are two fungal CYP51 proteins. This is the first report of the existence of two homologue genes coding for 14-alpha sterol demethylase in the fungal kingdom. This finding could provide insights into the azole resistance mechanisms operating in fungi. The primers used here may be useful molecular tools for facilitating the cloning of novel 14-alpha sterol demethylase genes in other filamentous fungi.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427550      PMCID: PMC88166          DOI: 10.1128/JCM.39.7.2431-2438.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  PCR cloning and detection of point mutations in the eburicol 14alpha-demethylase (CYP51) gene from Erysiphe graminis f. sp. hordei, a "recalcitrant" fungus.

Authors:  C Délye; L Bousset; M F Corio-Costet
Journal:  Curr Genet       Date:  1998-12       Impact factor: 3.886

Review 2.  Cytochrome P450 enzyme systems in fungi.

Authors:  H M van den Brink; R F van Gorcom; C A van den Hondel; P J Punt
Journal:  Fungal Genet Biol       Date:  1998-02       Impact factor: 3.495

Review 3.  Invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

4.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.

Authors:  E Chryssanthou
Journal:  Scand J Infect Dis       Date:  1997

7.  Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

Authors:  D W Denning; S A Radford; K L Oakley; L Hall; E M Johnson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

8.  Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.

Authors:  M Cuenca-Estrella; J L Rodríguez-Tudela; E Mellado; J V Martínez-Suárez; A Monzón
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

9.  In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

Authors:  C Lass-Flörl; G Kofler; G Kropshofer; J Hermans; A Kreczy; M P Dierich; D Niederwieser
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

10.  A novel ATP-binding cassette transporter involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum.

Authors:  R Nakaune; K Adachi; O Nawata; M Tomiyama; K Akutsu; T Hibi
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

View more
  120 in total

1.  Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.

Authors:  Yong Chen; Zhongyi Lu; Jingjun Zhao; Ziying Zou; Yanwen Gong; Fen Qu; Zhiyao Bao; Guangbin Qiu; Mingsheng Song; Qing Zhang; Lin Liu; Mandong Hu; Xuelin Han; Shuguang Tian; Jingya Zhao; Fangyan Chen; Changjian Zhang; Yansong Sun; Paul E Verweij; Liuyu Huang; Li Han
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Authors:  Simone M T Camps; Jan W M van der Linden; Yi Li; Ed J Kuijper; Jaap T van Dissel; Paul E Verweij; Willem J G Melchers
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).

Authors:  Sara J Blosser; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.

Authors:  G Garcia-Effron; E Mellado; A Gomez-Lopez; L Alcazar-Fuoli; M Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.

Authors:  E Mellado; G Garcia-Effron; M J Buitrago; L Alcazar-Fuoli; M Cuenca-Estrella; J L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole.

Authors:  Márcia Eliana da Silva Ferreira; Iran Malavazi; Marcela Savoldi; Axel A Brakhage; Maria Helena S Goldman; H Stanley Kim; William C Nierman; Gustavo H Goldman
Journal:  Curr Genet       Date:  2006-04-19       Impact factor: 3.886

7.  Overexpression of the 14alpha-demethylase target gene (CYP51) mediates fungicide resistance in Blumeriella jaapii.

Authors:  Zhonghua Ma; Tyre J Proffer; Janette L Jacobs; George W Sundin
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

8.  Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital.

Authors:  I Montesinos; M A Argudín; M Hites; F Ahajjam; M Dodémont; C Dagyaran; M Bakkali; I Etienne; F Jacobs; C Knoop; S Patteet; K Lagrou
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

9.  Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.

Authors:  Dawoon Chung; Arsa Thammahong; Kelly M Shepardson; Sara J Blosser; Robert A Cramer
Journal:  Mol Microbiol       Date:  2014-05-09       Impact factor: 3.501

10.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.